A 5-year follow-up of antioxidant supplementation in type 2 diabetic retinopathy

European Journal of Ophthalmology

Volumn 21, Issue 5, 2011, Pages 637-643

  Garcia Medina, Jose Javier ^a,b   Pinazo Duran, Maria Dolores ^a   Garcia Medina, Manuel ^c   Zanon Moreno, Vicente ^a   Pons Vazquez, Sheila ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b Hospital de Huercal Overa   (Spain)

^c HOSPITAL TORRECÁRDENAS   (Spain)

Author keywords

Antioxidants; Diabetic retinopathy; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CARBOHYDRATE; COPPER; FAT; MALONALDEHYDE; MANGANESE; MULTIVITAMIN; NICOTINIC ACID; PROTEIN; SELENIUM; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; VITALUX FORTE; XANTHOPHYLL; ZINC;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIET SUPPLEMENTATION; DISEASE COURSE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DIETARY SUPPLEMENTS; FEMALE; FLUOROMETRY; FOLLOW-UP STUDIES; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRACE ELEMENTS; VISUAL ACUITY; VITAMINS;

EID: 79960830758     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/EJO.2010.6212     Document Type: Article

References (37)

1. Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17: 24-38.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
3. Madsen-Bouterse SA, Kowluru RA. Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord 2008; 9: 315-27.
4. van Reyk DM, Gillies MC, Davies MJ. The retina: oxidative stress and diabetes. Redox Rep 2003; 8: 187-92.
5. Sabu MC, Smitha K, Ramadasan K. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol 2002; 83: 109-16.
6. Hammes HP, Du X, Edelstein D, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 2003; 9: 294-9.
7. Stahl W, Sies H. Bioactivity and protective effects of natural carotenoids. Biochim Biophys Acta 2005; 1740: 101-7.
8. Kowluru RA, Odenbach S. Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 2004; 53: 3233-8.
9. Moustafa SA. Zinc might protect oxidative changes in the retina and pancreas at the early stage of diabetic rats. Toxicol Appl Pharmacol 2004; 201: 149-55.
10. Berryman AM, Maritim AC, Sanders RA, Watkins JB III. Influence of treatment of diabetic rats with combinations of Pycnogenol, beta-carotene, and alpha-lipoic acid on parameters of oxidative stress. J Biochem Mol Toxicol 2004; 18: 345-52.
11. Mustata GT, Rosca M, Biemel KM, et al. Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking. Diabetes 2005; 54: 517-26.
12. Yatoh S, Mizutani M, Yokoo T, et al. Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy. Diabetes Metab Res Rev 2006; 22: 38-45.
13. Dene BA, Maritim AC, Sanders RA, Watkins JB III. Effects of antioxidant treatment on normal and diabetic rat retinal enzyme activities. J Ocul Pharmacol Ther 2005; 21: 28-35.
14. Yülek F, Or M, Ozogul C, et al. Effects of stobadine and vitamin E in diabetes-induced retinal abnormalities: involvement of oxidative stress. Arch Med Res 2007; 38: 503-11.
15. Kowluru RA, Kanwar M. Effect of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab 2007; 4: 8.
16. Kowluru RA, Menon B, Gierhart DL. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats. Invest Ophthalmol Vis Sci 2008; 49: 1645-51.
17. Kowluru RA, Kanwar M, Chan PS, Zhang JP. Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients. Arch Ophthalmol 2008; 126: 1266-72.
18. Arnal E, Miranda M, Johnsen-Soriano S, et al. Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats. Curr Eye Res 2009; 34: 928-38.
19. Mayer-Davis EJ, Bell RA, Reboussin BA, Rushing J, Marshall JA, Hamman RF. Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. Ophthalmology 1998; 105: 2264-70.
20. Millen AE, Gruber M, Klein R, Klein BE, Palta M, Mares JA. Relations of serum ascorbic acid and alpha-tocopherol to diabetic retinopathy in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2003; 158: 225-33.
21. Millen AE, Klein R, Folsom AR, Stevens J, Palta M, Mares JA. Relation between intake of vitamins C and E and risk of diabetic retinopathy in the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 2004; 79: 865-73.
22. Bursell S-E, Clermont A, Aiello LP, et al. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 1999; 22: 1245-51.
23. Spadea L, Balestrazi E. Treatment of vascular retinopathy with Pycnogenol. Phytother Res 2001; 15: 219-23.
24. Wilkinson CP, Ferris III F.L, Klein RE, et al, Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110: 1677-1682.
25. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15: 212-6.
26. Hendriks T, Assniann RFTA. On the fluorometric assay of circulating lipoperoxides. Clin Chim Acta 1988; 174: 263-9.
27. Conti M, Morand C, Levillain P, Lemmonnier A. Improved fluorometric determination of malondialdehyde. Clin Chem 1991; 37: 1273-5.
28. Richard MJ, Portal B, Moo J, Coudray C, Hadjian A, Favier A. Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin Chem 1992; 38: 704-9.
29. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993; 84: 407-12.
30. Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2010; 20;(1):CD003974.
31. Kowluru RA, Kanwar M. Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase- 2. Free Radic Biol Med 2009; 46: 1677-85.
32. Verdejo C, Marco P, Renau-Piqueras J, Pinazo-Duran MD. Lipid peroxidation in proliferative vitreoretinopathies. Eye 1999; 13: 183-8.
33. Augustin AJ, Dick HB, Koch F, Schmidt-Erfurth U. Correlation of blood-glucose control with oxidative metabolites in plasma and vitreous body of diabetic patients. Eur J Ophthalmol 2002; 12: 94-101.
34. Fong DS, Aiello LP, Ferris III F.L, Klein R. Diabetic retinopathy. Diabetes Care 2004; 27: 2540-53.
35. The AREDS Research Group. A randomized, placebo controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for agerelated macular degeneration and vision loss: AREDS Report No. 8. Arch Ophthalmol 2001; 119: 1417-36.
36. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 2004; 75: 216-30.
37. Stitt AW. AGEs and diabetic retinopathy. Invest Ophthalmol Vis Sci 2010; 51: 4867-74.